UK L-carnitine Market Size & Outlook, 2020-2028
UK l-carnitine market, 2017-2028 (US$M)
Related Markets
UK l-carnitine market highlights
- The UK l-carnitine market generated a revenue of USD 10.7 million in 2020 and is expected to reach USD 16.1 million by 2028.
- The UK market is expected to grow at a CAGR of 5.2% from 2021 to 2028.
- In terms of segment, bioprocess was the largest revenue generating process in 2020.
- Bioprocess is the most lucrative process segment registering the fastest growth during the forecast period.
L-carnitine market data book summary
| Market revenue in 2020 | USD 10.7 million |
| Market revenue in 2028 | USD 16.1 million |
| Growth rate | 5.2% (CAGR from 2020 to 2028) |
| Largest segment | Bioprocess |
| Fastest growing segment | Bioprocess |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemical Synthesis, Bioprocess |
| Key market players worldwide | Lonza Group Ltd, Neogen Corp, WuXi Biologics (Cayman) Inc, Merck KGaA, Tokyo Chemical Industry, CEVA Inc |
Other key industry trends
- In terms of revenue, UK accounted for 5.8% of the global l-carnitine market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany l-carnitine market is projected to lead the regional market in terms of revenue in 2028.
- France is the fastest growing regional market in Europe and is projected to reach USD 9.4 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
L-carnitine Market Scope
L-carnitine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK l-carnitine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to l-carnitine market will help companies and investors design strategic landscapes.
Bioprocess was the largest segment with a revenue share of 76.64% in 2020. Horizon Databook has segmented the UK l-carnitine market based on chemical synthesis, bioprocess covering the revenue growth of each sub-segment from 2017 to 2028.
According to a report published by the manufacturing organization EEF in 2018, increasing demand for personalized treatments coupled with the rising manufacturing technologies is likely to augment the growth of pharmaceutical industry in the UK.
In addition, the country is investing majorly in research & development and is anticipated to emerge as a leading pharmaceutical industry across the globe with almost 10% of the country’s GDP contributing to healthcare expenditure.
The major pharmaceutical corporations have their presence in the UK. Moreover, the top 2 companies, GlaxoSmithKline plc and AstraZeneca, among the top 10 global pharmaceutical companies have their headquarters located in the UK, which is expected to drive the growth of pharmaceutical industry.
Reasons to subscribe to UK l-carnitine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK l-carnitine market databook
-
Our clientele includes a mix of l-carnitine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK l-carnitine market , including forecasts for subscribers. This country databook contains high-level insights into UK l-carnitine market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
UK l carnitine market size, by process, 2017-2028 (US$M)
UK L-carnitine Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
